In recent years, there has been great progress in the development of new antirheumatic drugs for rheumatoid arthritis, such as TNFα inhibitors, IL-6 receptor antagonists, and inhibitors targeting the JAK pathway. Here, TNF is linked to rheumatoid arthritis.